22142382|t|Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease.
22142382|a|INTRODUCTION: Docosahexaenoic acid (DHA) and DHA-containing ethanolamine plasmalogens (PlsEtn) are decreased in the brain, liver and the circulation in Alzheimer's disease. Decreased supply of plasmalogen precursors to the brain by the liver, as a result of peroxisomal deficits is a process that probably starts early in the AD disease process. To overcome this metabolic compromise, we have designed an orally bioavailable DHA-containing ether lipid precursor of plasmalogens. PPI-1011 is an alkyl-diacyl plasmalogen precursor with palmitic acid at sn-1, DHA at sn-2 and lipoic acid at sn-3. This study outlines the oral pharmacokinetics of this precursor and its conversion to PlsEtn and phosphatidylethanolamines (PtdEtn). METHODS: Rabbits were dosed orally with PPI-1011 in hard gelatin capsules for time-course and dose response studies. Incorporation into PlsEtn and PtdEtn was monitored by LC-MS/MS. Metabolism of released lipoic acid was monitored by GC-MS. To monitor the metabolic fate of different components of PPI-1011, we labeled the sn-1 palmitic acid, sn-2 DHA and glycerol backbone with (13)C and monitored their metabolic fates by LC-MS/MS. RESULTS: PPI-1011 was not detected in plasma suggesting rapid release of sn-3 lipoic acid via gut lipases. This conclusion was supported by peak levels of lipoic acid metabolites in the plasma 3 hours after dosing. While PPI-1011 did not gain access to the plasma, it increased circulating levels of DHA-containing PlsEtn and PtdEtn. Labeling experiments demonstrated that the PtdEtn increases resulted from increased availability of DHA released via remodeling at sn-2 of phospholipids derived from PPI-1011. This release of DHA peaked at 6 hrs while increases in phospholipids peaked at 12 hr. Increases in circulating PlsEtn were more complex. Labeling experiments demonstrated that increases in the target PlsEtn, 16:0/22:6, consisted of 2 pools. In one pool, the intact precursor received a sn-3 phosphoethanolamine group and desaturation at sn-1 to generate the target plasmalogen. The second pool, like the PtdEtn, resulted from increased availability of DHA released during remodeling of sn-2. In the case of sn-1 18:0 and 18:1 plasmalogens with [(13)C(3)]DHA at sn-2, labeling was the result of increased availability of [(13)C(3)]DHA from lipid remodeling. Isotope and repeated dosing (2 weeks) experiments also demonstrated that plasmalogens and/or plasmalogen precursors derived from PPI-1011 are able to cross both the blood-retinal and blood-brain barriers. CONCLUSIONS: Our data demonstrate that PPI-1011, an ether lipid precursor of plasmalogens is orally bioavailable in the rabbit, augmenting the circulating levels of unesterified DHA and DHA-containing PlsEtn and PtdEtn. Other ethanolamine plasmalogens were generated from the precursor via lipid remodeling (de-acylation/re-acylation reactions at sn-2) and phosphatidylethanolamines were generated via de-alkylation/re-acylation reactions at sn-1. Repeated oral dosing for 2 weeks with PPI-1011 resulted in dose-dependent increases in circulating DHA and DHA-containing plasmalogens. These products and/or precursors were also able to cross the blood-retinal and blood-brain barriers.
22142382	28	51	ether lipid plasmalogen	Chemical	-
22142382	63	71	PPI-1011	Chemical	MESH:C000711075
22142382	80	86	rabbit	Species	9986
22142382	119	138	Alzheimer's disease	Disease	MESH:D000544
22142382	154	174	Docosahexaenoic acid	Chemical	MESH:D004281
22142382	176	179	DHA	Chemical	MESH:D004281
22142382	185	188	DHA	Chemical	MESH:D004281
22142382	200	225	ethanolamine plasmalogens	Chemical	MESH:C020791
22142382	227	233	PlsEtn	Chemical	-
22142382	292	311	Alzheimer's disease	Disease	MESH:D000544
22142382	333	344	plasmalogen	Chemical	MESH:D010955
22142382	398	418	peroxisomal deficits	Disease	MESH:D018901
22142382	466	476	AD disease	Disease	MESH:D000544
22142382	565	568	DHA	Chemical	MESH:D004281
22142382	580	591	ether lipid	Chemical	-
22142382	605	617	plasmalogens	Chemical	MESH:D010955
22142382	619	627	PPI-1011	Chemical	MESH:C000711075
22142382	634	658	alkyl-diacyl plasmalogen	Chemical	-
22142382	674	687	palmitic acid	Chemical	MESH:D019308
22142382	697	700	DHA	Chemical	MESH:D004281
22142382	704	708	sn-2	Gene	100302413
22142382	713	724	lipoic acid	Chemical	MESH:D008063
22142382	820	826	PlsEtn	Chemical	-
22142382	831	856	phosphatidylethanolamines	Chemical	MESH:D010714
22142382	858	864	PtdEtn	Chemical	MESH:D010714
22142382	907	915	PPI-1011	Chemical	MESH:C000711075
22142382	1003	1009	PlsEtn	Chemical	-
22142382	1014	1020	PtdEtn	Chemical	MESH:D010714
22142382	1071	1082	lipoic acid	Chemical	MESH:D008063
22142382	1164	1172	PPI-1011	Chemical	MESH:C000711075
22142382	1194	1207	palmitic acid	Chemical	MESH:D019308
22142382	1209	1213	sn-2	Gene	100302413
22142382	1214	1217	DHA	Chemical	MESH:D004281
22142382	1222	1230	glycerol	Chemical	MESH:D005990
22142382	1245	1250	(13)C	Chemical	MESH:C000615229
22142382	1309	1317	PPI-1011	Chemical	MESH:C000711075
22142382	1373	1389	sn-3 lipoic acid	Chemical	-
22142382	1455	1466	lipoic acid	Chemical	MESH:D008063
22142382	1521	1529	PPI-1011	Chemical	MESH:C000711075
22142382	1600	1603	DHA	Chemical	MESH:D004281
22142382	1615	1621	PlsEtn	Chemical	-
22142382	1626	1632	PtdEtn	Chemical	MESH:D010714
22142382	1677	1683	PtdEtn	Chemical	MESH:D010714
22142382	1734	1737	DHA	Chemical	MESH:D004281
22142382	1765	1769	sn-2	Gene	100302413
22142382	1773	1786	phospholipids	Chemical	MESH:D010743
22142382	1800	1808	PPI-1011	Chemical	MESH:C000711075
22142382	1826	1829	DHA	Chemical	MESH:D004281
22142382	1865	1878	phospholipids	Chemical	MESH:D010743
22142382	2010	2016	PlsEtn	Chemical	-
22142382	2096	2120	sn-3 phosphoethanolamine	Chemical	-
22142382	2175	2186	plasmalogen	Chemical	MESH:D010955
22142382	2214	2220	PtdEtn	Chemical	MESH:D010714
22142382	2262	2265	DHA	Chemical	MESH:D004281
22142382	2296	2300	sn-2	Gene	100302413
22142382	2336	2348	plasmalogens	Chemical	MESH:D010955
22142382	2355	2364	(13)C(3)]	Chemical	-
22142382	2364	2367	DHA	Chemical	MESH:D004281
22142382	2371	2375	sn-2	Gene	100302413
22142382	2431	2440	(13)C(3)]	Chemical	-
22142382	2440	2443	DHA	Chemical	MESH:D004281
22142382	2449	2454	lipid	Chemical	MESH:D008055
22142382	2540	2552	plasmalogens	Chemical	MESH:D010955
22142382	2560	2571	plasmalogen	Chemical	MESH:D010955
22142382	2596	2604	PPI-1011	Chemical	MESH:C000711075
22142382	2711	2719	PPI-1011	Chemical	MESH:C000711075
22142382	2724	2735	ether lipid	Chemical	-
22142382	2749	2761	plasmalogens	Chemical	MESH:D010955
22142382	2792	2798	rabbit	Species	9986
22142382	2850	2853	DHA	Chemical	MESH:D004281
22142382	2858	2861	DHA	Chemical	MESH:D004281
22142382	2873	2879	PlsEtn	Chemical	-
22142382	2884	2890	PtdEtn	Chemical	MESH:D010714
22142382	2898	2923	ethanolamine plasmalogens	Chemical	MESH:C020791
22142382	2962	2967	lipid	Chemical	MESH:D008055
22142382	3019	3023	sn-2	Gene	100302413
22142382	3029	3054	phosphatidylethanolamines	Chemical	MESH:D010714
22142382	3158	3166	PPI-1011	Chemical	MESH:C000711075
22142382	3219	3222	DHA	Chemical	MESH:D004281
22142382	3227	3230	DHA	Chemical	MESH:D004281
22142382	3242	3254	plasmalogens	Chemical	MESH:D010955
22142382	Association	MESH:C000711075	MESH:D019308
22142382	Positive_Correlation	MESH:C000711075	MESH:D004281
22142382	Association	MESH:D004281	100302413
22142382	Association	MESH:C020791	MESH:D004281
22142382	Association	MESH:C000615229	MESH:D004281
22142382	Negative_Correlation	MESH:C000711075	MESH:D000544
22142382	Positive_Correlation	MESH:C000711075	MESH:D010714
22142382	Association	MESH:C000711075	100302413
22142382	Association	MESH:D010955	MESH:D018901
22142382	Association	MESH:C000615229	100302413
22142382	Association	MESH:C000711075	MESH:D010743
22142382	Negative_Correlation	MESH:D004281	MESH:D000544
22142382	Negative_Correlation	MESH:C020791	MESH:D000544
22142382	Association	MESH:D004281	MESH:D010714
22142382	Association	MESH:C000615229	MESH:D019308
22142382	Association	MESH:D010955	MESH:D000544

